Literature DB >> 19350386

A novel orthotopic and metastatic mouse model of breast cancer in human mammary microenvironment.

Jue Wang1, Tian-Song Xia, Xiao-An Liu, Qiang Ding, Qing Du, Hong Yin, Shui Wang.   

Abstract

The studies of breast cancer heavily rely on the availability of experimental animal models. An ideal model of breast cancer is not only required to mimic the whole processes of tumor progress and metastasis, but also required to provide a normal human mammary microenvironment for the breast cancer cells to proliferate and metastasize. Numerous mouse models have been introduced in the literature but failed to achieve the two requirements simultaneously. In this study, we developed a novel human breast tissue-derived orthotopic and metastatic (BOM) mouse model of breast cancer, in which the normal human breast tissues were implanted subcutaneously to create a normal human mammary microenvironment, after which the human breast cancer cells were inoculated into the implants. The BOM model not only mimicked the whole processes of tumor progress and metastasis, but also allowed the orthotopic human breast cancer cells to proliferate in the normal human mammary microenvironment, and finally metastasize preferentially to the distant human tissues. Consequently, the BOM model contributed to the orthotopic tumor formation of 100% (11/11) and the metastatic tumor formation of 72.7% (8/11).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19350386     DOI: 10.1007/s10549-009-0391-4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  11 in total

Review 1.  Modeling metastasis in the mouse.

Authors:  Paula D Bos; Don X Nguyen; Joan Massagué
Journal:  Curr Opin Pharmacol       Date:  2010-07-01       Impact factor: 5.547

2.  Screening and analysis of breast cancer genes regulated by the human mammary microenvironment in a humanized mouse model.

Authors:  Mingjie Zheng; Jue Wang; Lijun Ling; Dandan Xue; Shui Wang; Yi Zhao
Journal:  Oncol Lett       Date:  2016-10-24       Impact factor: 2.967

3.  Human mammary microenvironment better regulates the biology of human breast cancer in humanized mouse model.

Authors:  Ming-Jie Zheng; Jue Wang; Lu Xu; Xiao-Ming Zha; Yi Zhao; Li-Jun Ling; Shui Wang
Journal:  Med Oncol       Date:  2015-01-09       Impact factor: 3.064

4.  Preclinical humanized mouse model with ectopic ovarian tissues.

Authors:  Shilong Fu; Jue Wang; Wu Sun; Yi Xu; Xiaoyu Zhou; Wenjun Cheng
Journal:  Exp Ther Med       Date:  2014-07-01       Impact factor: 2.447

5.  Human stromal cells are required for an anti-breast cancer effect of zoledronic acid.

Authors:  Hilde H Nienhuis; Marlous Arjaans; Hetty Timmer-Bosscha; Elisabeth G E de Vries; Carolina P Schröder
Journal:  Oncotarget       Date:  2015-09-15

6.  Shikonin reduces tamoxifen resistance through long non-coding RNA uc.57.

Authors:  Chen-Han Zhang; Jue Wang; Lin-Xin Zhang; Yi-Han Lu; Tian-Hao Ji; Lu Xu; Li-Jun Ling
Journal:  Oncotarget       Date:  2017-09-11

7.  Interaction Between Ezrin and Cortactin in Promoting Epithelial to Mesenchymal Transition in Breast Cancer Cells.

Authors:  Jing He; Ge Ma; Jiayi Qian; Yichao Zhu; Mengdi Liang; Na Yao; Qiang Ding; Lin Chen; Xiaoan Liu; Tiansong Xia; Shui Wang
Journal:  Med Sci Monit       Date:  2017-04-01

8.  RNPC1 enhances progesterone receptor functions by regulating its mRNA stability in breast cancer.

Authors:  Peipei Lou; Chunlian Li; Liang Shi; Tian-Song Xia; Wenbin Zhou; Jing Wu; Xujie Zhou; Xiaoxia Li; Ying Wang; Ji-Fu Wei; Qiang Ding
Journal:  Oncotarget       Date:  2017-03-07

Review 9.  Role of the Microenvironment in Regulating Normal and Cancer Stem Cell Activity: Implications for Breast Cancer Progression and Therapy Response.

Authors:  Vasudeva Bhat; Alison L Allan; Afshin Raouf
Journal:  Cancers (Basel)       Date:  2019-08-24       Impact factor: 6.639

Review 10.  Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities.

Authors:  Maria Laura De Angelis; Federica Francescangeli; Ann Zeuner
Journal:  Cancers (Basel)       Date:  2019-10-15       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.